Neurogenesis Targeting Therapies For Neurodegenerative Diseases is a treatment approach for neurodegenerative diseases. This page provides comprehensive information about its mechanism of action, clinical evidence, and therapeutic potential.
Neurogenesis, the process of generating new neurons from neural stem cells, occurs primarily in two regions of the adult mammalian brain: the subventricular zone (SVZ) of the lateral ventricles and the subgranular zone (SGZ) of the dentate gyrus in the hippocampus. These neural stem cells (NSCs) can proliferate, differentiate, and integrate into existing neural circuits, offering potential for brain repair in neurodegenerative conditions.
In neurodegenerative diseases, endogenous neurogenesis is often impaired or insufficient to compensate for progressive neuronal loss. Various factors contribute to this impairment: chronic neuroinflammation, oxidative stress, protein aggregate accumulation, and age-related decline in growth factor signaling. Neurogenesis-targeting therapies aim to overcome these barriers by:
The therapeutic goal is not merely to increase the number of new neurons, but to ensure their proper differentiation, migration, and functional integration into neural circuits relevant to each disease context.
Neurogenesis targeting in AD focuses on the hippocampus, where neuronal loss contributes to memory impairment. Strategies include:
In PD, neurogenesis approaches aim to replace dopaminergic neurons in the substantia nigra:
Post-stroke neurogenesis is naturally elevated, and therapeutic approaches aim to enhance this response:
The study of Neurogenesis Targeting Therapies For Neurodegenerative Diseases has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Note: This page is part of the NeuroWiki treatment database. Last updated: 2026-03-04